- Home
- KNDI vs ACHV Comparison
KNDI vs ACHV Comparison
Compare KNDI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- ACHV
- Stock Information
- Founded
- KNDI 2002
- ACHV N/A
- Country
- KNDI China
- ACHV Canada
- Employees
- KNDI N/A
- ACHV N/A
- Industry
- KNDI Auto Manufacturing
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- KNDI Consumer Discretionary
- ACHV Health Care
- Exchange
- KNDI Nasdaq
- ACHV Nasdaq
- Market Cap
- KNDI 154.6M
- ACHV 149.6M
- IPO Year
- KNDI N/A
- ACHV N/A
- Fundamental
- Price
- KNDI $0.96
- ACHV $4.20
- Analyst Decision
- KNDI
- ACHV Strong Buy
- Analyst Count
- KNDI 0
- ACHV 5
- Target Price
- KNDI N/A
- ACHV $14.80
- AVG Volume (30 Days)
- KNDI 233.9K
- ACHV 113.3K
- Earning Date
- KNDI 11-18-2024
- ACHV 11-07-2024
- Dividend Yield
- KNDI N/A
- ACHV N/A
- EPS Growth
- KNDI N/A
- ACHV N/A
- EPS
- KNDI N/A
- ACHV N/A
- Revenue
- KNDI $118,127,232.00
- ACHV N/A
- Revenue This Year
- KNDI N/A
- ACHV N/A
- Revenue Next Year
- KNDI N/A
- ACHV N/A
- P/E Ratio
- KNDI N/A
- ACHV N/A
- Revenue Growth
- KNDI N/A
- ACHV N/A
- 52 Week Low
- KNDI $0.96
- ACHV $3.20
- 52 Week High
- KNDI $3.13
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- KNDI 30.77
- ACHV 38.91
- Support Level
- KNDI $0.97
- ACHV $4.02
- Resistance Level
- KNDI $1.04
- ACHV $4.66
- Average True Range (ATR)
- KNDI 0.07
- ACHV 0.17
- MACD
- KNDI -0.00
- ACHV -0.02
- Stochastic Oscillator
- KNDI 5.00
- ACHV 23.44
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.